CD38 and systemic lupus erythematosus: Our results highlight the importance of the immunoregulatory role of CD38 in inflammation and in the development of systemic autoimmunity leading to lupus, which should be considered when designing CD38-specific therapies for the treatment of inflammatory and autoimmune diseases.